Improving the stability of insulin in solutions containing intestinal proteases in vitro

International Journal of Molecular Sciences

Volumn 9, Issue 12, 2008, Pages 2376-2387

  Liefeng, Zhang ^a   Hui, Jiang ^a   Wenjie, Zhu ^a   Lin, Wu ^a   Lingling, Song ^a   Qiuyan, Wu ^a   Yong, Ren ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

Casein; Cyclodextrin; Degradation; Insulin; Protamine; Protection

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CASEIN; INSULIN; INTESTINE ENZYME; PHOSPHORYLASE PHOSPHATASE; PROINSULIN; PROTAMINE; PROTEINASE;

ABSORPTION; ARTICLE; COMPETITION; IN VITRO STUDY; INSULIN DEGRADATION; INTESTINE; PROTEIN DEGRADATION; PROTEIN STABILITY; SOLUTION AND SOLUBILITY; ULTRAVIOLET RADIATION; ULTRAVIOLET SPECTROSCOPY;

EID: 58149216451     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms9122376     Document Type: Article

References (31)

1. 1 H NMR. J. Pharmaceut. Biomed. 2002, 29, 487-494.
2. Cefalu, W.T. Concept strategies and feasibility of non-invasive insulin delivery. Diabetes Care 2004, 27, 230-246.
3. Lin, C.; Gokhale, R.; Trivedi, J.S.; Ranade, V. Recent strategies and methods for improving insulin delivery. Drug Develop. Res, 2004, 63, 151-160.
4. Khafagy, E.S.; Morishita, M.; Onuki, Y.; Takayama, K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliver. Rev. 2007, 59, 1521-1546.
5. Frokjaer, S. Otez, D.D. Protein drug stability: a formulation challage. Nat. Rev, Drug Discov. 2005, 4, 298-306.
6. Agarwal, V.; Nazzal, S.; Reddy, I.K.; Khan, M.A. Transport studies of insulin across rat jejunum in the presence of chicken and duck ovomucoids. J. Pharm. Pharmacol. 2001, 53, 1131-1138.
7. Yamamoto, A.; Taniguchi, T.; Rikyuu, K.; Tsuji, T.; Fujita, T.; Murakami, M.; Muranishi, S. Effect of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 1994, 11, 1496-1500.
8. Kotze, A.F.; Lueβen, H.L.; Leeuw, B.J.; de Boer, B.G.; Verhoef, J.C.; Junginger, H.E. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2). Pharm. Res. 1997, 14, 1197-1202.
9. Bernkop-Schnurch, A.; Krauland, A.H.; Leitner, V.M.; Palmberger, T. Thiomers: Potential excipients for non-invasive peptide delivery systems. Eur. J. Pharm. Biopharm. 2004, 58, 253-263.
10. Yamagata, T.; Morishita, M.; Kavimandan, N.J.; Nakamura, K.; Fukuoka, Y.; Takayama, K.; Peppas, N.A. Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. J. Control. Release 2006, 112, 343-349.
11. Playford, R.J.; Woodman, A.C.; Vesey, D.; Deprez, P.H.; Calam, J.; Watanapa, P.; Williamson, R.C.N.; Clark, P. Effect of luminal growth factor preservation on intestinal growth. Lancet. 1993, 341, 843-848.
12. Playford, R.J.; Marchbank, T.; Calnan, D.P.; Calam, J.; Royston, P.; Batten, J.J.; Hansen, H.F. Epidermal growth factor is digested to smaller, less active forms in acid gastric juice. Gastroenterology 1995, 108, 92-101.
13. Amorim, M.J.; Ferreira, J.P. Microparticles for delivering therapeutic peptides and proteins to the lumen of the small intestine. Eur. J. Pharm. Biopharm. 2001, 52, 39-44.
14. Aachmann, F.L.; Otzen, D.E.; Larsen, K.L.; Wimmer, R. Structural background of cyclodextrin-protein interactions. Protein Eng. 2003, 16, 905-912.
15. Irie, T.; Uekama, K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 1999, 36, 101-123.
16. Moses, R.; Dileep, K.J.; Sharma, C.P. Beta cyclodextrin-insulin- encapsulated chitosan/alginate matrix: Oral delivery system. J. Appl. Polym. Sci. 2000, 75, 1089-1096.
17. Sajeesh, S.; Sharma, C.P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 2006, 325, 147-154.
18. Lovatt, M.; Cooper, A.; Camilleri, P. Energetics of cyclodextrin-induced dissociation of insulin. Eur. Biophys. J. 1996, 24, 354-357.
19. Zannou, E.A.; Streng, W.H.; Stella, V.J. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins. Pharm. Res. 2001, 18, 1226-1231.
20. Rosa, G.D.; Larobina, D.; Immacolata, M.; Rotonda, L.; Musto, P.; Quaglia, P.; Quaglia, F.; Ungaro, F. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-β-cyclodextrin system. J. Control. Release 2005, 102, 71-83.
21. Qi, R.; Ping, Q.N.; Xu, R.Y.; Shi, Y.P. Effect of casein and protamine on the enzymatic degradation and the orally hypoglycemic action of insulin. Acta Pharmaceut. Sinica 2004, 39, 844-848.
22. Schilling, R.J.; Mitra, A.K. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm. Res. 1991, 8, 721-727.
23. Ungaro, F.; Rosa, G.D.; Miro, A.; Quaglia, F.; Rotonda, M.I.L. Cyclodextrins in the protection of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur. J. Pharm. Sci. 2006, 28, 423-432.
24. Yang, T.; Hussain, A.; Paulson, J.; Abbruscato, T.J.; Ahsan, F. Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies. Pharm. Res. 2004, 21, 1127-1136.
25. Le, Z.; Yong, R. Study on the inclusion of insulin and β-cyclodextrin. Chinese Acad. Mag. Organisms 2003, 3, 53-56.
26. Shao, Z.; Li, Y.P; Chermak, T.; Mitra, A.K. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin. Pharm. Res. 1994, 11, 1174-1179.
27. Todo, H.; Okamoto, H.; Iida, K.; Danjo, K. Improvement of stability and absorbalility of dry insulin powder for inhalation by powder-combination technique. Int. J. Pharm. 2004, 271, 41-52.
28. Laemmli, U.K. Cleavage of structural proteins during the assay of the head of bacteriophage T4. Nature 1970, 277, 680-685.
29. Tang, C.; Yin, C.H.; Pei, Y.Y.; Yu, L.; Cui, F.Y. Study on the stability of oral insulin in gastrointestinal tract. Chin. Pharm. J. 2004, 39, 764-766.
30. Kano, K.; Nishiyabu, R.; Asada, T.; Kuroda, Y. Static and Dynamic Behavior of 2:1 Inclusion Complexes of Cyclodextrins and Charged Porphyrins in Aqueous Organic Media. J. Am. Chem. Soc. 2002, 124, 9937-9944.
31. Iwanaga, K.; Ono, S.; Narioka, K.; Morimoto, K.; Kakemi, M.; Yamashita, S.; Nango, M.; Oku, N. Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract. Int. J. Pharm. 1997, 157, 73-80.